Hydreight Technologies Inc. (TSXV:NURS)

Hydreight Technologies Statistics

Total Valuation

TSXV:NURS has a market cap or net worth of CAD 168.94 million. The enterprise value is 158.63 million.

Market Cap	168.94M
Enterprise Value	158.63M

Important Dates

The last earnings date was Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	n/a

Share Statistics

TSXV:NURS has 47.32 million shares outstanding. The number of shares has increased by 13.29% in one year.

Current Share Class	47.32M
Shares Outstanding	47.32M
Shares Change (YoY)	+13.29%
Shares Change (QoQ)	+4.97%
Owned by Insiders (%)	3.28%
Owned by Institutions (%)	1.10%
Float	20.45M

Valuation Ratios

The trailing PE ratio is 372.74 and the forward PE ratio is 13.73.

PE Ratio	372.74
Forward PE	13.73
PS Ratio	6.90
PB Ratio	17.83
P/TBV Ratio	23.56
P/FCF Ratio	232.84
P/OCF Ratio	232.20
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 211.53, with an EV/FCF ratio of 218.62.

EV / Earnings	349.98
EV / Sales	6.48
EV / EBITDA	211.53
EV / EBIT	n/a
EV / FCF	218.62

Financial Position

The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.88.

Current Ratio	4.47
Quick Ratio	4.26
Debt / Equity	0.88
Debt / EBITDA	11.10
Debt / FCF	11.47
Interest Coverage	2.70

Financial Efficiency

Return on equity (ROE) is 11.78% and return on invested capital (ROIC) is 2.83%.

Return on Equity (ROE)	11.78%
Return on Assets (ROA)	1.81%
Return on Invested Capital (ROIC)	2.83%
Return on Capital Employed (ROCE)	2.03%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.95
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +202.42% in the last 52 weeks. The beta is 0.74, so TSXV:NURS's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	+202.42%
50-Day Moving Average	4.59
200-Day Moving Average	2.68
Relative Strength Index (RSI)	36.52
Average Volume (20 Days)	154,372

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSXV:NURS had revenue of CAD 24.48 million and earned 453,235 in profits. Earnings per share was 0.01.

Revenue	24.48M
Gross Profit	7.14M
Operating Income	362,248
Pretax Income	453,235
Net Income	453,235
EBITDA	749,891
EBIT	362,248
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 18.64 million in cash and 8.32 million in debt, giving a net cash position of 10.31 million or 0.22 per share.

Cash & Cash Equivalents	18.64M
Total Debt	8.32M
Net Cash	10.31M
Net Cash Per Share	0.22
Equity (Book Value)	9.47M
Book Value Per Share	0.20
Working Capital	15.50M

Cash Flow

In the last 12 months, operating cash flow was 727,566 and capital expenditures -1,995, giving a free cash flow of 725,571.

Operating Cash Flow	727,566
Capital Expenditures	-1,995
Free Cash Flow	725,571
FCF Per Share	0.02

Margins

Gross margin is 29.16%, with operating and profit margins of 1.48% and 1.85%.

Gross Margin	29.16%
Operating Margin	1.48%
Pretax Margin	1.85%
Profit Margin	1.85%
EBITDA Margin	3.06%
EBIT Margin	1.48%
FCF Margin	2.96%

Dividends & Yields

TSXV:NURS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.29%
Shareholder Yield	-13.29%
Earnings Yield	0.27%
FCF Yield	0.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 25, 2022. It was a reverse split with a ratio of 0.1546061.

Last Split Date	Nov 25, 2022
Split Type	Reverse
Split Ratio	0.1546061

Scores

TSXV:NURS has an Altman Z-Score of 5.21 and a Piotroski F-Score of 5.

Altman Z-Score	5.21
Piotroski F-Score	5